ANVS Stock Catalyst: Annovis Bio Reports New Biomarker Data on Parkinson's Cognitive Decline

Nov 17, 2025 · 10:22am ET

Company reveals findings on amyloid co-pathology and cognitive decline.

Max move

+68.8%

High of day $4.00

Sparker timei

10:22am ET

ANVS · Nov 17, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Annovis Bio, Inc. announced on 2025-11-17 Annovis Bio reported new biomarker data linking amyloid co-pathology to accelerated cognitive decline in Parkinson's patients.

Reductions in plasma biomarkers pTau217, total tau, and brain-derived tau. The announcement cited 25%, and three-times greater response.

Annovis Bio, Inc. has a free float of 17,065,100 shares and 26,114,700 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time ANVS sparks.

Download Sniper App →

Catch the next ANVS-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →